Prof Sylvie Lantuejoul, MD, PhD

April 1, 2016

|

By

|

Estimated Read Time:

1–2 minutes

Prof Sylvie Lantuejoul moved in May 2015 to Centre Léon Bérard, a cancer institute under the aegis of the Unicancer Consortium in Lyon, France. She continues as Professor in Pathology at the Grenoble Alpes University. Prof Lantuejoul also works for the National Reference Center, MESOPATH-dir Pr F Galateau-Sallé, a French network dedicated to the diagnosis of mesothelioma and rare tumors of the peritoneum and translational research in these diseases.

About the Authors

Share this Article:

Prof Sylvie Lantuejoul, MD, PhD

Recent Posts

IASLC Launches Beta Version of VIKTOR

Patient Charts: How to Carefully Manage Patient Access to Health Information

CAN-2409 Plus Valacyclovir Extends Survival in ICI-Refractory NSCLC

Using Early ctDNA, Study Findings Inform Prognostic Model

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection

Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging

No PFS, OS Benefit Seen in Final Results from PACIFIC-2

WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

A Holistic Approach to Patient Care